Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation
- PMID: 21961716
- PMCID: PMC3185243
- DOI: 10.1016/j.ogc.2011.05.006
Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation
Abstract
Vasomotor symptoms (VMS), or hot flashes and night sweats, are often considered the cardinal symptoms of menopause. SWAN, one of the largest and most ethnically diverse longitudinal studies of the menopausal transition, has allowed unique insights into VMS. Specifically, SWAN has helped yield important information about the prevalence of, racial/ethnic differences in, risk factors for, and implications of VMS for midlife women's mental and physical health. We have reviewed the literature on VMS, emphasizing findings that have emerged from SWAN and new areas of inquiry in the area of VMS.
Similar articles
-
Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation.Fertil Steril. 2013 Sep;100(3):793-800. doi: 10.1016/j.fertnstert.2013.05.005. Epub 2013 Jun 10. Fertil Steril. 2013. PMID: 23755948 Free PMC article.
-
Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies.Climacteric. 2024 Feb;27(1):75-80. doi: 10.1080/13697137.2023.2196001. Epub 2023 Aug 14. Climacteric. 2024. PMID: 37577812 Free PMC article. Review.
-
Duration of menopausal vasomotor symptoms over the menopause transition.JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063. JAMA Intern Med. 2015. PMID: 25686030 Free PMC article.
-
The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN).Menopause. 2019 Oct;26(10):1213-1227. doi: 10.1097/GME.0000000000001424. Menopause. 2019. PMID: 31568098 Free PMC article. Review.
-
Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).Menopause. 2017 Jan;24(1):9-26. doi: 10.1097/GME.0000000000000723. Menopause. 2017. PMID: 27749738 Free PMC article.
Cited by
-
Cocoa-Rich Chocolate and Quality of Life in Postmenopausal Women: A Randomized Clinical Trial.Nutrients. 2020 Sep 10;12(9):2754. doi: 10.3390/nu12092754. Nutrients. 2020. PMID: 32927668 Free PMC article. Clinical Trial.
-
Understanding Attitudes, Beliefs, and Behaviors Surrounding Menopause Transition: Results from Three Surveys.Patient Relat Outcome Meas. 2022 Dec 14;13:273-286. doi: 10.2147/PROM.S375144. eCollection 2022. Patient Relat Outcome Meas. 2022. PMID: 36540377 Free PMC article.
-
The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?Menopause. 2019 Sep;26(9):1071-1084. doi: 10.1097/GME.0000000000001326. Menopause. 2019. PMID: 31453973 Free PMC article. Review.
-
Vasomotor symptoms, sleep problems, and depressive symptoms in community-dwelling Japanese women.J Obstet Gynaecol Res. 2021 Oct;47(10):3677-3690. doi: 10.1111/jog.14937. Epub 2021 Jul 18. J Obstet Gynaecol Res. 2021. PMID: 34278662 Free PMC article.
-
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause.Adv Ther. 2024 May;41(5):1885-1895. doi: 10.1007/s12325-024-02821-0. Epub 2024 Mar 11. Adv Ther. 2024. PMID: 38467985 Free PMC article.
References
-
- Freeman EW, Grisso JA, Berlin J, et al. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause. 2001;8(1):33–42. - PubMed
-
- Barnabei VM, Cochrane BB, Aragaki AK, et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women’s Health Initiative. Obstet Gynecol. 2005;105(5 Pt 1):1063–1073. - PubMed
-
- Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol. 2002;100(6):1209–1218. - PubMed
-
- Randolph JF, Jr., Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab. 2005;90(11):6106–6112. - PubMed
Publication types
MeSH terms
Grants and funding
- AG012553/AG/NIA NIH HHS/United States
- NR004061/NR/NINR NIH HHS/United States
- AG012554/AG/NIA NIH HHS/United States
- AG029216/AG/NIA NIH HHS/United States
- AG012539/AG/NIA NIH HHS/United States
- R01 MH082922/MH/NIMH NIH HHS/United States
- AG012505/AG/NIA NIH HHS/United States
- AG012535/AG/NIA NIH HHS/United States
- AG012546/AG/NIA NIH HHS/United States
- K23 AG029216/AG/NIA NIH HHS/United States
- AG012531/AG/NIA NIH HHS/United States
- NH082922/NH/NIH HHS/United States
- AG012495/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical